Biora Therapeutics Inc (NAS:BIOR)
$ 0.6399 0.0317 (5.21%) Market Cap: 22.96 Mil Enterprise Value: 57.76 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q3 2021 Progenity Inc Earnings Call Transcript

Nov 10, 2021 / 09:30PM GMT
Release Date Price: $88 (+3.23%)
Operator

Good day, and thank you for standing by. Welcome to the Progenity Third Quarter 2021 Earnings Call. At this time, all participants are in a listen only mode.

(Operator Instructions).

I would now like to turn the call over to our moderator today, Robert Uhl, Managing Director with ICR Westwicke, Progenity's Investor Relations firm. Thank you. Please go ahead.

Robert Uhl
Progenity, Inc. - Managing Director of ICR, Investor Relations

Thank you, operator. Good afternoon, and welcome to Progenity's Third Quarter 2021 Financial Results Conference Call. Joining me on the call is Adi Mohanty, the new CEO of Progenity; and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our quarterly report on Form 10-Q that we will file later today and our subsequent periodic reports filed with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot